Overview Rating

Speculative

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Technicals Analysis

0100

Financials Analysis

0100

TransCode Therapeutics (NASDAQ:RNAZ) Stock Quotes, Forecast and News Summary

Q: What sector and industry does TransCode Therapeutics (RNAZ) operate in?

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.

Open	$0.82
Close	$0.79
Volume / Avg.	83.51K / 1.25M
Day Range	0.78 - 0.84
52 Wk Range	0.42 - 128.00
Market Cap	$4.86M
P/E Ratio	0.01
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.3%
Days to Cover	1

Recent News

Why TransCode Therapeutics (RNAZ) Stock Is Getting Hammered

TransCode Therapeutics shares are trading lower by 40.6% during Monday's session. The company disclosed plans for a potential reverse stock split in an open letter to its shareholders.

Henry Khederian

Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-expected thi

Avi Kapoor

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About TransCode Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disea...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy TransCode Therapeutics (RNAZ) stock?

You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.

View our list of the best stock brokerages

Who are TransCode Therapeutics (RNAZ) competitors?

Other companies in TransCode Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), NuCana (NASDAQ:NCNA), Portage Biotech (NASDAQ:PRTG) and AquaBounty Techs (NASDAQ:AQB).

What is the target price for TransCode Therapeutics (RNAZ) stock?

There is no analysis for TransCode Therapeutics.

What is the forecast for TransCode Therapeutics (RNAZ) stock?

TransCode Therapeutics has a consensus price target of $3.00.

Current stock price for TransCode Therapeutics (RNAZ)?

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.6692 last updated Today at July 22, 2024 at 4:16 PM EDT.

Does TransCode Therapeutics (RNAZ) pay a dividend?

There are no upcoming dividends for TransCode Therapeutics.

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

TransCode Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is TransCode Therapeutics (RNAZ) going to split?

There is no upcoming split for TransCode Therapeutics.

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

TransCode Therapeutics

TransCode Therapeutics (RNAZ) Forecast